LU91303I2 - Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP - Google Patents

Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP

Info

Publication number
LU91303I2
LU91303I2 LU91303C LU91303C LU91303I2 LU 91303 I2 LU91303 I2 LU 91303I2 LU 91303 C LU91303 C LU 91303C LU 91303 C LU91303 C LU 91303C LU 91303 I2 LU91303 I2 LU 91303I2
Authority
LU
Luxembourg
Prior art keywords
vhvt013
gallivac
hvt
ibd
pfu
Prior art date
Application number
LU91303C
Other languages
English (en)
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/823,102 external-priority patent/US5068192A/en
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of LU91303I2 publication Critical patent/LU91303I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16762—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU91303C 1986-01-27 2007-01-12 Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP LU91303I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/823,102 US5068192A (en) 1986-01-27 1986-01-27 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
US88714086A 1986-07-17 1986-07-17
US90288786A 1986-09-02 1986-09-02
US93310786A 1986-11-20 1986-11-20

Publications (1)

Publication Number Publication Date
LU91303I2 true LU91303I2 (fr) 2007-03-12

Family

ID=27505864

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91303C LU91303I2 (fr) 1986-01-27 2007-01-12 Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP

Country Status (5)

Country Link
EP (1) EP0794257B1 (fr)
AT (2) ATE342996T1 (fr)
CA (1) CA1339468C (fr)
DE (3) DE122007000004I1 (fr)
LU (1) LU91303I2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0965639A1 (fr) * 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Pestivirus atténués
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
ES2635019T3 (es) 2010-10-18 2017-10-02 Intervet International B.V. Vacuna con vector del herpesvirus de pavo contra la gripe aviar en aves de corral
WO2013057235A1 (fr) 2011-10-21 2013-04-25 Intervet International B.V. Vecteur mdv non pathogène recombinant conférant une immunité multivalente
MX352206B (es) 2011-10-21 2017-11-13 Intervet Int Bv Contrucciones no patogenicas recombinantes del virus de la enfermedad de marek que codifican para antigenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad de newcastle.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190254A4 (fr) * 1984-07-05 1987-03-09 Genex Corp Gene clone et son procede de preparation et d'utilisation.

Also Published As

Publication number Publication date
EP0794257B1 (fr) 2006-10-18
DE3752389D1 (de) 2006-11-30
DE3752389T2 (de) 2007-06-14
DE3752182D1 (de) 1998-05-14
DE3752182T2 (de) 1998-08-06
DE122007000004I1 (de) 2007-05-24
CA1339468C (fr) 1997-09-23
ATE342996T1 (de) 2006-11-15
EP0794257A1 (fr) 1997-09-10
ATE164885T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
SI0935660T1 (sl) Infekcijski kloni RNA virusov ter cepiva in diagnostični testi, izvedeni iz le-teh
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
IL101780A0 (en) Recombinant avipox virus,the culture of cells infected with this virus and vaccines for poultry derived from this virus
AU3142889A (en) A recombinant marek's disease virus and a vaccine
EP0261940A3 (fr) Vaccins pseudorabiques et vecteurs d'ADN pour recombiner avec les poxvirus
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
EP0256677A3 (fr) Recombinants du virus pseudorabies et leur utilisation pour la production de protéines
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
DK498387D0 (da) Virus-dna-sekvens
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DE68929544D1 (de) Virale Vakzine
DK0623172T3 (da) Rekombinant Mareks sygdomsvirus-poxvirusvaccine
ATE46264T1 (de) Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis.